BRCA1 and breast cancer: In conclusion, the aim of our study is to determine whether DNA-direct is an acceptable procedure for BRCA1/2 testing, in order to provide customized care to patients with breast cancer and remove unnecessary waiting times within the diagnostic process, cutting down on the long period of uncertainty that patients are currently faced with.